MedTrace Logo

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

NCT00653393 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2008-04-04

No results posted yet for this study

Summary

To compare the single-dose Bioavailability of Tranylcypromine and Parnate

Conditions

  • To Determine the Bioavailability of Tranylcypromine

Interventions

DRUG

Tranylcypromine

Tablets, 10 mg, single-dose

DRUG

Parnate

Tablets, 10 mg, single-dose

Sponsors & Collaborators

  • SFBC Ft. Myers, Inc

    collaborator INDUSTRY

  • Par Pharmaceutical, Inc.

    lead INDUSTRY

Principal Investigators

  • Antonio Pizzaro · SFBC Ft. Myers, Inc

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2004-11-30
Completion
2004-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00653393 on ClinicalTrials.gov